Prostate cancer: the common male cancer and the PSA question

Last updated September 3, 2026.

Start a free AI doctor consult by text

Prostate cancer is the commonest cancer in men: arising in the prostate gland, usually growing slowly (the many men die WITH it rather than OF it), but the aggressive kinds exist and the finding-them-early matters. The early disease usually causes no symptoms (the urinary symptoms mostly come from the benign enlargement, a separate thing), the PSA blood test starts the checking, and the treatments span the active-surveillance (the monitored-not-treated kind, right for the low-risk) through the surgery and the radiotherapy, with the outcomes for the localized kind running excellent.

What are the symptoms?

The early kind: usually none (the silent row: found by the PSA). The urinary rows (the weak stream, the frequency, the night-getting-up, the hesitancy) usually mean the benign enlargement instead, but deserve the checking. The advanced-kind signs: the bone pain (the back-hips-ribs: the persistent kind), the blood in the urine-or-semen, and the unexplained weight loss. The family history (the father-brother kind, the BRCA rows, the Black ethnicity) raises the risk.

The PSA question

The PSA is the useful-but-imperfect blood test: the raised kind triggers the MRI (the biopsy targeted from it), and it misses-some-and-over-finds-some (the slow-kind cancers treated that would never have harmed: the over-treatment the real problem the surveillance solves). The current pathway (the PSA, then the MRI before any biopsy) has reduced the unnecessary biopsies.

Find answers to prostate cancer

Start a free AI doctor consult →

How is it treated?

When does it need checking?

The within-weeks for: the urinary changes (the any-new kind in the over-50s), the bone pain, the blood in the urine-or-semen, and the PSA-question conversation for the over-50s (the over-45s for the family-history-or-Black-ethnicity rows). Pymander's escalation routing is built and tested specifically for this class of decision; see the safety architecture working paper.

What a Pymander AI doctor consult looks like

Have you had a raised PSA, urinary symptoms, a prostate-cancer diagnosis, or questions about testing?
I am 62 and my routine PSA came back at 6.5, up from 4.1 two years ago. I have some night-time urination but otherwise feel fine. My father had prostate cancer at 70. I have an MRI booked. Should I be preparing for bad news?
Thanks for giving me all this information. Based on what you've said, the preparation answer: prepare for the information, not the verdict, because the PSA of 6.5 with the rise from 4.1 sits in the ambiguous zone (the benign enlargement raises it, the inflammation raises it, the cancer raises it: the number itself cannot vote), and your pathway is exactly the modern right one (the MRI before any biopsy: the scan seeing whether the suspicious area even exists: the many MRIs at your PSA-level come back clean-or-reassuring, and the pathway stops there). The family history raises your background risk (the father-kind row), which is the argument for the keeping-the-monitoring, not for the expecting-the-worst: and even the found-kind framing: the prostate cancer found at the MRI-and-biopsy stage in the PSA-monitored man is usually the early-caught kind, where the options include the active surveillance (the many low-risk men never treated: the watched kind) and the curative rows with the excellent outcomes. The night-time urination is the likely-benign-enlargement row (the separate, the common, the treatable). The practical: the MRI answers in the weeks, the no-preparation-but-the-presence kind (the questions written down, the someone-along if it helps), and the interim is for the living, not the bracing. Here's your care note to share with your care team.
Care note
PSA 6.5 rising, 62 with FHx - MRI-first pathway explained, surveillance destigmatized
Sixty-two-year-old: PSA 6.5 (from 4.1 two years ago), night-time urination, father with prostate cancer at 70, MRI booked: the modern MRI-first diagnostic pathway mid-flight. Plan: the ambiguous-zone framing (PSA cannot vote; benign causes raise it), the pathway validated (MRI-first reduces unnecessary biopsies), the family history reframed as monitor-more not expect-worst, the even-if-found framing (early-caught = surveillance-eligible or excellent-outcome curative rows), and the night-urination parked as likely-benign-enlargement. No false reassurance, no bracing.
View care note →

Illustrative example, not a real member's messages.

Common questions

Does a PSA of 6.5 mean I have cancer?

The not row: the PSA is the smoke-alarm, not the fire (the benign enlargement raises it steadily with the age, the recent ejaculation-cycling-inflammation raise it transiently, and the plenty of 6.5-kind readings come from the entirely-benign prostates), while the rising-trend kind (your 4.1-to-6.5 row) is what the MRI sorts: the suspicious-area-present kind earns the targeted biopsy, the clean-kind MRI ends the worry. The number started the looking: it does not decide the answer.

My father had it. How much does that raise my risk?

The roughly-doubling row (the one first-degree relative: the father-or-brother kind), with the age-and-number-of-relatives modulating it, and the practical consequence: the earlier-and-regular PSA checking (the from-45-kind rows for the family-history men), which you are already doing. The hereditary-kind rows (the BRCA2 especially: the breast-ovarian-kind families) sit behind some prostate cancers: the worth-mentioning row if your family carries the other cancers too. The raised risk is the reason for the vigilance you already show: it is working.

If they find cancer, will I need surgery or radiation?

The increasingly-often-neither row: the prostate cancers split into the kinds (the low-risk slow-growers vs the treatment-deserving kind), and the low-risk rows now get the active surveillance (the regular PSA-plus-MRI-plus-occasional-biopsy: the treatment only if the disease moves: the large trials showing the surveillance-kind survival equal to the immediate-treatment kind), so the diagnosis no longer means the automatic operation. The treatment-kind rows (the surgery, the radiotherapy) remain excellent when the needed, with the choice hinging on the side-effect preferences.

What are the treatment side effects? I have heard about incontinence.

The honest-profile row: the surgery carries the early-incontinence (the mostly-recovering over the months: the small-percentage-kind lasting) and the erection-changes (the nerve-sparing improving the odds: the age-and-baseline mattering), the radiotherapy carries the bowel-kind bother and the later-erection drift, and the hormone therapy adds the hot-flushes-fatigue-bones rows: all the manageable, all the discussable, and the reason the surveillance exists for the low-risk: the no-treatment-kind side-effects are the none. The decisions get made with the urologist-and-oncologist rows spelling out YOUR numbers.

Is the night-time urination a cancer symptom?

The usually-not row: the nocturia (the getting-up kind) comes mostly from the benign enlargement (the gland growing inward on the urethra: the near-universal aging-kind row) and the other causes (the evening fluids, the caffeine, the sleep-apnea kind), while the prostate cancer classically causes the NO urinary symptoms until the late (the growing-outward kind). Your symptom still gets mentioned at the appointments (the treatment rows for the enlargement help the nights), but it is the separate-track row from the cancer question.

What happens at and after the MRI?

The scan itself: the 30-40-minutes kind (the lying-still, the noisy, the no-needles-usually row), then the reporting (the days-to-week kind), and the three outcomes: the clean-kind (the back-to-monitoring: the PSA rhythm continues), the ambiguous (the repeat-or-biopsy-discussion), and the suspicious (the targeted biopsy: the local-anesthetic day-case kind: the pathology answering in the week-kind). Each branch is the known pathway: nothing at your stage is the unmapped territory, and the results-appointment questions written in advance help.

Sources

Pymander is not a replacement for a physician and does not provide medical advice, diagnosis, or treatment.

Free AI doctor, 24/7 by textStart a free AI doctor consult